Clinical Trial Update: Cytochrome P450 2D6 (CYP 450 2D6) Genotype and Flecainide Efficacy

View source ↗

Summary

An update on a clinical trial evaluating whether CYP2D6 genotype affects the efficacy of flecainide for atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• flecainide (flecainide)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Atrial Fibrillation | Status: UNKNOWN